One-step assay for the determination of free protein S antigen in plasma using real-time biospecific interaction analysis

Blood Coagulation and Fibrinolysis

Volumn 9, Issue 4, 1998, Pages 333-341

  Ravanat, C ^a   Wiesel, M L ^a   Schuhler, S ^a   Dambach, J ^a   Amiral, J ^b   Cazenave, J P ^a  

^a INSERM   (France)

^b Laboratoires de Recherche   (France)

Author keywords

Biospecific interactions; Free protein S; Immunoassay; Surface plasmon resonance; Thrombophilic states

Indexed keywords

PROTEIN S;

ANIMAL EXPERIMENT; ANTICOAGULATION; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; HUMAN; IMMUNOASSAY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; THROMBOPHILIA; THROMBOSIS;

EID: 0031830596     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199806000-00005     Document Type: Article

References (36)

1. Walker FJ. Regulation of activated protein C by a new protein. A possible function for bovine protein S. J Biol Chem 1980; 255: 5521-5524.
2. Walker FJ. Regulation vitamin K-dependent protein S, inactivation by thrombin. J Biol Chem 1984; 259: 10335-10339.
3. Comp PC, Nixon RR, Cooper MR, Esmon CT. Familial protein S deficiency is associated with recurrent thrombosis. J Clin Invest 1984; 74: 2082-2088.
4. Schwarz HP, Fischer M, Hopmeier P, Batar MA, Griffin JH. Plasma protein S deficiency in familial thrombotic disease. Blood 1984; 64: 1297-1300.
5. Boyer-Neumann C, Wolf M, Amiral J, Guyader AM, Meyer D, Larricu MJ. Familial Type I protein S deficiency associated with severe thrombosis. A study of five cases. Thromb Haemost 1988; 60: 128.
6. Siè P, Boneu B, Biermè R, Wiesel ML, Grunebaum L, Cazenave JP. Arterial thrombosis and protein S deficiency. Thromb Haemost 1989; 62: 1040.
7. Dahlback B, Stenflo J. High molecular weight complex in human plasma between vitamin K-dependent protein S and complement component C4b-binding protein. Proc Natl Acad Sci USA 1981; 78: 2512-2516.
8. Dahlback B. Purification of human C4b-binding protein and formation of its complex with vitamin K-dependent protein S. Biochem J 1983; 209: 847-856.
9. Dahlback B. Inhibition of protein Ca cofactor function of human and bovine protein S by C4b-binding protein. J Biol Chem 1986; 261: 12022-12027.
10. Woodhams BJ. The simultaneous measurement of total and free protein S by ELISA. Thromb Res 1988; 50: 213-220.
11. Deutz-Terlow PP, Ballering L, van Wijngaarden A, Bertina RM. Two ELISAs for measurement of protein S, and their use in the laboratory diagnosis of protein S deficiency. Clin Chem Acta 1989; 186: 321-334.
12. Jennings I, Luddington RJ. An enzyme-linked immunosorbent assay for measurement of protein S. Med Lab Sci 1989; 46: 50-53.
13. Comp PC, Doray D, Patton D, Esmon CT. Abnormal plasma distribution of protein S occurs in functional protein S deficiency. Blood 1986; 67: 504-508.
14. Espana F, Hendl S, Aznar J, Gilabert J, Estellés A. Determination of total, free and complexed protein S in plasma by ELISA, and comparison with a standard electroimmunoassay. Thromb Res 1991; 62: 615-624.
15. Bertina RM. The specificty of protein C and protein S assays. Res Clin Lab 1990; 20: 127-138.
16. Amiral J, Grosley B, Boyer-Neumann C, Marfaing-Koka A, Peynaud-Debayle E, Wolf M, et al. New direct assay of free protein S antigen using two distinct monoclonal antibodies specific for the free form. Blood Coag Fibrinol 1994; 5: 179-186.
17. Wolf M, Boyer-Neumann C, Peynaud-Debayle E, Marfaing-Koka A, Amiral J, Meyer D. Clinical applications of a direct assay of protein S antigen using monoclonal antibodies. A study of 59 cases. Blood Coag Fibrinol 1994; 5: 187-192.
18. Fagerstäm LG, Frostell-Karlsson A, Karlsson R, Persson B, Rönnberg I. Biospecific interaction analysis using surface plasmon resonance detection applied to kinetic, binding site and concentration analysis. J Chromat 1992; 597: 397-410.
19. Minunni M. Simultaneous determination of β2-macroglobulin and IgE using real-time biospecific interaction analysis (BIA). Anal Lett 1995; 28: 933-944.
20. Van Cott TC, Bethke FR, Burke DS, Redfield RR, Birx DL. Lack of induction of antibodies specific for conserved, discontinuous epitopes of HIV-1 envelope glycoprotein by candidates AIDS vaccines. J Immunol 1995; 155: 4100-4110.
21. Van Cott TC, Loomis LD, Redfield RR, Birx DL. Real-time biospecific interaction analysis of antibody reactivity to peptides from the envelope glycoprotein, GP160 of HIV-1. J Immunol Methods 1992; 146: 163-176.
22. Allauzen S, Mani JC, Granier C, Pau B, Bouanani M. Epitope mapping and binding analysis of insulin-specific monoclonal antibodies using a biosensor approach. J Immunol Methods 1995; 183: 27-32.
23. Arnout J, Spitz B, Wittevrongel C, Vanrusselt M, Van Assche A, Vermylen J. High-dose intravenous immunoglobulin treatment of a pregnant patient with an antiphospholipid syndrome: immunological changes associated with a successful outcome. Thromb Haemost 1994; 71: 741-747.
24. Bakker R, Lasonder E, Bos NA. Measurement of affinity in serum samples of antigen germ-free and conventional mice after hyperimmunization with 2,4-dinitrophenyl keyhole limpet hemocyanin, using surface plasmon resonance. Eur J Immunol 1995; 25: 1680-1686.
25. Karlsson R, Fägerstam L, Nilshans H, Persson B. Analysis of active antibody concentration. Separation of affinity and concentration parameters. J Immunol Methods 1993; 166: 75-84.
26. Karlsson R, Stahlberg R. Surface plasmon resonance detection and multi-sensing for direct monitoring of interactions involving low molecular weight analytes and for determination of low affinities. Anal Biochem 1995; 228: 274-280.
27. Sternesjö A, Mellgren C Bösrck L. Determination of sulfamethazine residues in milk by surface plasmon resonance-base biosensor assay. Anal Biochem 1995; 226: 175-181.
28. Minunni M, Mascini M. Detection of pesticide in drinking waters using real-time biospecific interaction analysis (BIA). Anal Lett 1993; 26: 1441-1460.
29. Freyssinet JM, Schuhler S, Schuhler E, Gauchy J, Ravanat C, Wiesel ML, et al. Vitamin K-dependent proteins of plasma: structure-function relationships, purification and therapeutic applications. In: Biotechnology of Plasma Proteins. JF Stolz, Rivat C (editors). Paris: Colloque Inserm (175), 1989. pp. 305-314.
30. Laurell CB, McKay EJ. Electroimmunoassay. Methods Enzymol 1981; 73: 339-369.
31. Wiesel ML, Charmantier JL, Freyssinet JM, Grunebaum L, Schuhler S, Cazenave JP. Screening of protein S deficiency using functional assay in patients with venous and arterial thrombosis. Thromb Res 1990; 58: 461-468.
32. Tripodi A, Bertina RM, Conard J, Pabinger I, Sala N, Mannuci PM. Multicenter evaluation of three commercial methods for measuring protein S antigen. Thromb Haemost 1992; 68: 149-154.
33. Wong RL, Mytych D, Jacobs S, Bordens R, Swanson SJ. Validation parameters for a novel biosensor assay which simultaneously measures serum concentrations of a humanized monoclonal antibody and detects induced antibodies. J Immunol Methods 1998; 209: 1-15.
34. Boerger LM, Morris PC, Thurnau GR, Esmon CT, Comp PC. Oral contraceptives and gender protein S status. Blood 1987; 69: 692-694.
35. Ravanat C, Freund M, Dol F, Cadroy Y, Roussi J, Incardona F, et al. Cross-reactivity of human molecular markers for detection of prethrombotic states in various animal species. Blood Coag Fibrinol 1995; 6: 446-455.
36. Ravanat C, Freund M, Schuhler S, Grunert P, Meyer L, Cazenave J.-P. Species specific immunoassays to measure blood platelet and coagulation activation in the rat. Thromb Haemost 1996; 76: 1090-1095.